Skip to content

Author

Janani Gopalakrishnan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

In vivo CAR-T therapy: The shift from ex vivo culturing to direct in situ immune reprogramming.

This review highlights key engineering strategies enabling in vivo CAR T-cell generation, summarizes emerging clinical research and development, and discusses future opportunities for expanding in vivo CAR T-cell therapies as scalable immunotherapy platforms.

Janani Gopalakrishnan, B. Rathod, Sachin Puri · 0 citations